Skip to main content
Premium Trial:

Request an Annual Quote

Robert Quint, Janet Wright, Chung-Jui Tsai, Jennifer Pearson Medlin, Jing “Jim” Li, John Gilroy, Edward Tannebaum, Derek Potter

Premium

California Treasurer Names San Jose Cardiologist to Stem-Cell Agency’s Governing Board
 
Robert Quint, a San Jose, Calif., cardiologist, has been appointed by California Treasurer Bill Lockyer to the Independent Citizens Oversight Commission, the governing board of the state agency charged with spending $3 billion on stem-cell research and facilities.
 
Quint succeeds Janet Wright as the designated heart disease patient advocate on the 29-member ICOC, which oversees the California Institute for Regenerative Medicine. Wright has moved to Washington, DC, to accept a job as vice president for science and quality at the American College of Cardiology.
 
Quint has operated his own cardiology practice in San Jose since 1980. From 1971 to 1980, he was a partner at the Western Heart Association in San Jose. Before moving to California, Quint practiced from 1968 through 1971 in the Department of Cardiology Vascular Services at the Cleveland Clinic Foundation. He has helped develop diagnostic and treatment techniques for arteriosclerotic heart disease, including coronary angiography and angioplasty.
 

 
Biofuel Researcher Chung-Jui Tsai Joins UGA’s Forestry School as GRA Eminent Scholar
 
Chung-Jui Tsai has been recruited for the University of Georgia’s Warnell School of Forestry and Natural Resources through the Georgia Research Alliance’s Eminent Scholar program.

Tsai holds the Winfred N. “Hank” Haynes Professorship in forest biotechnology. Her research will focus on creating high-energy yielding trees for use in biofuel, as an alternative to ethanol derived from corn and other food crops.

A native of Taiwan, Tsai has a PhD in forest science from Michigan Technological University, where she also taught for 11 years in its School of Forest Resources and Environmental Sciences. She was the director of the interdisciplinary Biotechnology Research Center at MTU from 2002 to 2007.

Tsai holds five patents that involve methods for modifying lignin, a component that acts as glue in trees but also hinders efforts to extract cellulose for biofuel production. Tsai will also study how trees ward off bugs and grazing animals, with the goal of creating “smarter” trees.

 
Tsai is GRA’s 60th eminent scholar, and the 16th recruited to UGA. Eminent scholars are scientists recruited to state universities through GRA funds because their research is deemed to have potential for yielding economic benefits to the state.
 

 
Morris, Manning & Martin Adds to Intellectual Property Practice in Atlanta, Washington, DC
 
Jennifer Pearson Medlin and Jing “Jim” Li have joined the law firm of Morris, Manning & Martin. Medlin, a registered US patent attorney, joins the Atlanta office in an “of counsel” position, while Li joins the Washington DC office as a registered patent agent.
 
Prior to joining the firm, Medlin was a partner at the Atlanta IP boutique firm Needle & Rosenberg, acquired earlier this year by the law firm Ballard Spahr Andrews & Ingersoll. She earlier served as chief patent counsel and manager of outside counsel at BellSouth Corp.; and a patent examiner at the US Patent & Trademark Office.
 
Medlin’s practice focuses on medical devices as well as telecommunications, Internet, software, power systems, optics, and antennas. She has prosecuted hundreds of US and international patent applications, conducted due diligence studies, managed portfolios numbering in the thousands of patents, as a former in-house attorney with an international telecommunications company, written non-infringement and invalidity opinions, and negotiated intellectual property terms as part of mergers, acquisitions and supplier/vendor contracts.
 
Medlin is a guest teacher for both Georgia State Law School and Teaching Institute for Graduate Education Research, or TIGER. She represents pro bono victims of Hurricane Katrina and abused immigrants.
 
She received her law degree from Georgetown University Law Center, and her bachelor’s degree from the Georgia Institute of Technology in electrical engineering.
 
Li’s practice focuses on patent prosecution in biotechnology, molecular biology, biochemistry, cell biology, physiology, pharmacology, immunology, neuroscience, biophysics and protein chemistry.
Li has had over 10 years of academic research experience prior to moving into patent practice. He has held positions at Columbia University, New York University, the Max Planck Institute for Biophysics in Frankfurt and the Chinese Academy of Sciences.
 
Li received his PhD in molecular cell biology from the Max Planck Institute, and the Institute of Cell Biology at the Chinese Academy of Sciences in Shanghai. He earned his master’s degree in physiology from Nanjing University, and his bachelor’s degree in biology from Anhui Normal University, both located in China.
 

 
IPS Promotes Two Executives to New Construction, Strategic Planning Positions
 
Integrated Project Services, an engineering and construction firm specializing in assisting pharmaceutical and biotechnology companies, has promoted two executives:
  • John Gilroy has been named general manager of construction. A professional engineer who previously served as senior director of engineering, Gilroy will oversee the strategic direction and overall management of IPS’ construction division, including construction management, program management, pre-construction and design/build services.
  • Edward Tannebaum has been named president of IPS’ new entity Strategic Planning Initiatives, specializing in facilities management consulting services for technology-intense customers. SPI also offers owner representation, related program development and expert management consultation services.

    Gilroy has more than 20 years’ experience in project management, engineering and construction for the pharmaceutical and biotechnology industries — specifically in pharmaceutical manufacturing. Tannebaum, an architect, offers more than 35 years of design, facility management and construction experience, having served in senior management roles at several major construction service firms and large pharmaceutical companies.

 
BioTrove Appoints Derek Potter Director of European Business Operations
 
Derek Potter, a 30-year veteran of the genomic and protein tools industry, has been appointed by BioTrove to lead the development of its first European office (See Around the Regions, this issue) as director of European business operations. Potter will be responsible for strategy, sales, customer support and management of dealer networks in the European market.
 
Before joining BioTrove, Potter worked with Applied Biosystems, where he served as the first European sales manager, growing sales from zero to $3 million in the first year, as well as establishing direct sales and support operations in Germany, the UK, France, Italy and the Netherlands. Potter also worked with Fluidigm, where he played a key role in establishing the European operation.
 
Potter has a BSci degree in biochemistry from the University of Manchester Institute of Science and Technology.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.